Bangladesh national guidelines on the management of tuberculosis and diabetes mellitus co-morbidity (summary)

Mohammad Delwar Hossain; Jamal Uddin Ahmed; Muhammad Abdur Rahim; A K M Musa; Zafar Ahmed Latif

doi:10.4103/2230-8210.192898

Bangladesh national guidelines on the management of tuberculosis and diabetes mellitus co-morbidity (summary)

Indian J Endocrinol Metab. 2016 Nov-Dec;20(6):853-857. doi: 10.4103/2230-8210.192898.

Authors

Mohammad Delwar Hossain¹, Jamal Uddin Ahmed¹, Muhammad Abdur Rahim², A K M Musa¹, Zafar Ahmed Latif³

Affiliations

¹ Department of Internal Medicine and Pulmonology, BIRDEM General Hospital and Ibrahim Medical College, Dhaka, Bangladesh.
² Department of Nephrology, BIRDEM General Hospital and Ibrahim Medical College, Dhaka, Bangladesh.
³ Department of Endocrinology, BIRDEM General Hospital and Ibrahim Medical College, Dhaka, Bangladesh.

Abstract

Tuberculosis (TB) and diabetes mellitus (DM) have synergetic relationship. People with diabetes are 2-3 times at higher risk of getting active TB disease. On the other hand, TB or anti-TB treatment may cause glucose intolerance. The dual disease of DM and TB is more likely to be associated with atypical disease presentation, higher probability of treatment failure and complications. In most of the health-care delivery systems of the world, DM and TB are managed separately by two vertical health-care delivery programs in spite of clear interaction between the two diseases. Thus, there should be a uniform management service for TB-DM co-morbidity. Realizing this situation, Bangladesh Diabetic Samity (BADAS), a nonprofit, nongovernment organization for the management of diabetes in Bangladesh, with the patronization of TB CARE II Project funded by U.S. Agency for International Development (USAID), launched a project in 2013 titled BADAS-USAID TB Care II, Bangladesh with the goal of "Integrated approach to increase access to TB services for diabetic patients." One of the project objective and activity was to develop a national guideline for the management of TB-DM comorbidity. Thus, under the guidance of National Tuberculosis Control Program, of the Directorate General of Health Services, Government of the People's Republic of Bangladesh and World Health Organization (WHO), this guideline was developed in 2014. It is based on the existing "National Guidelines and Operational Manual for TB Control" (5^th edition) and guidelines for management of DM as per WHO and International Diabetes Federations. Along with that, expert opinions from public health experts and clinicians and "Medline"-searched literature were used to develop the guidelines. These guidelines illustrate the atypical presentation of the TB-DM co-morbidity, recommendations for screening, treatment, and follow-up of these patients and also recommendations in case of management of TB in patients with kidney and liver diseases. Thus, these guidelines will be a comprehensive tool for physicians to manage TB in diabetic patients.

Keywords: Bangladesh; co-morbidity; diabetes mellitus; guidelines; tuberculosis.

Publication types

Review